Glutamatergic Modulation of Disordered Alcohol Use
Clinical trial NCT02539511 · COMPLETED
Trial details
- NCT number
- NCT02539511
- Sponsor
- New York State Psychiatric Institute
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.